These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26075834)

  • 21. Metabolite profiles of degarelix, a new gonadotropin-releasing hormone receptor antagonist, in rat, dog, and monkey.
    Sonesson A; Koechling W; Stalewski J; Tankó LB; Rasmussen BB
    Drug Metab Dispos; 2011 Oct; 39(10):1895-903. PubMed ID: 21768273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
    Erion MD; Cable EE; Ito BR; Jiang H; Fujitaki JM; Finn PD; Zhang BH; Hou J; Boyer SH; van Poelje PD; Linemeyer DL
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15490-5. PubMed ID: 17878314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of isosteviol in the rat isolated perfused liver.
    Jin H; Wang J; Gerber JP; Davey AK
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):593-7. PubMed ID: 20082626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats.
    Villicev CM; Freitas FR; Aoki MS; Taffarel C; Scanlan TS; Moriscot AS; Ribeiro MO; Bianco AC; Gouveia CH
    J Endocrinol; 2007 Apr; 193(1):21-9. PubMed ID: 17400799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphenol a glucuronide, a major metabolite in rat bile after liver perfusion.
    Inoue H; Yokota H; Makino T; Yuasa A; Kato S
    Drug Metab Dispos; 2001 Aug; 29(8):1084-7. PubMed ID: 11454725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine.
    Grover GJ; Egan DM; Sleph PG; Beehler BC; Chiellini G; Nguyen NH; Baxter JD; Scanlan TS
    Endocrinology; 2004 Apr; 145(4):1656-61. PubMed ID: 14701670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generating an in vitro-in vivo correlation for metabolism and liver enrichment of a hepatitis C virus drug, faldaprevir, using a rat hepatocyte model (HepatoPac).
    Ramsden D; Tweedie DJ; St George R; Chen LZ; Li Y
    Drug Metab Dispos; 2014 Mar; 42(3):407-14. PubMed ID: 24366905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonist.
    Fujitaki JM; Cable EE; Ito BR; Zhang BH; Hou J; Yang C; Bullough DA; Ferrero JL; van Poelje PD; Linemeyer DL; Erion MD
    Drug Metab Dispos; 2008 Nov; 36(11):2393-403. PubMed ID: 18703645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide.
    Kochansky CJ; Xia YQ; Wang S; Cato B; Creighton M; Vincent SH; Franklin RB; Reed JR
    Drug Metab Dispos; 2005 Dec; 33(12):1894-904. PubMed ID: 16183782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition of bazedoxifene in rats.
    Chandrasekaran A; Ahmad S; Shen L; DeMaio W; Hultin T; Scatina J
    Xenobiotica; 2010 Aug; 40(8):578-85. PubMed ID: 20528166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide.
    Kimoto E; Li R; Scialis RJ; Lai Y; Varma MV
    Mol Pharm; 2015 Nov; 12(11):3943-52. PubMed ID: 26378985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
    Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
    Takeuchi K; Sugiura T; Umeda S; Matsubara K; Horikawa M; Nakamichi N; Silver DL; Ishiwata N; Kato Y
    Drug Metab Dispos; 2011 Jun; 39(6):1088-96. PubMed ID: 21422191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct-cannulated rats.
    Chen Y; Cheng D; Marugan JJ; Manthey C; Tomczuk B; Huebert N
    Biopharm Drug Dispos; 2008 May; 29(4):219-30. PubMed ID: 18260095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and structure-activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl]malonamic acids as thyroid hormone receptor β (TRβ) selective agonists.
    Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Matsuzawa A; Nagano R; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
    Bioorg Med Chem; 2013 Feb; 21(3):592-607. PubMed ID: 23276448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, tissue distribution and identification of putative metabolites of JI-101 - a novel triple kinase inhibitor in rats.
    Gurav SD; Gilibili RR; Jeniffer S; Mohd Z; Giri S; Govindarajan R; Srinivas NR; Mullangi R
    Arzneimittelforschung; 2012 Jan; 62(1):27-34. PubMed ID: 22331760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration.
    Perra A; Kowalik MA; Cabras L; Runfola M; Sestito S; Migliore C; Giordano S; Chiellini G; Rapposelli S; Columbano A
    Cell Prolif; 2020 May; 53(5):e12808. PubMed ID: 32347601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotransformation of an alpha4beta2 nicotinic acetylcholine receptor partial agonist in sprague-dawley rats and the dispositional characterization of its N-carbamoyl glucuronide metabolite.
    Shaffer CL; Ryder TF; Venkatakrishnan K; Henne IK; O'Connell TN
    Drug Metab Dispos; 2009 Jul; 37(7):1480-9. PubMed ID: 19339375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T3 and the thyroid hormone beta-receptor agonist GC-1 differentially affect metabolic capacity and oxidative damage in rat tissues.
    Venditti P; Chiellini G; Bari A; Di Stefano L; Zucchi R; Columbano A; Scanlan TS; Di Meo S
    J Exp Biol; 2009 Apr; 212(Pt 7):986-93. PubMed ID: 19282495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The thyroid hormone receptor (TR) beta-selective agonist GC-1 inhibits proliferation but induces differentiation and TR beta mRNA expression in mouse and rat osteoblast-like cells.
    Beber EH; Capelo LP; Fonseca TL; Costa CC; Lotfi CF; Scanlan TS; Gouveia CH
    Calcif Tissue Int; 2009 Apr; 84(4):324-33. PubMed ID: 19280098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.